Zobrazeno 1 - 10
of 386
pro vyhledávání: '"CHANGPING WU"'
Publikováno v:
Cancer Biology & Therapy, Vol 25, Iss 1 (2024)
To explore role of NAALADL2-AS2 as ceRNA in DLBCL. Fluorescence in situ hybridization was used to determine location of NAALADL2-AS2 in cells and to verify its expression in DLBCL tissues. The miRNAs interacting with NAALADL2-AS2 and related regulato
Externí odkaz:
https://doaj.org/article/5e15e97e17f14e6f83924508becd3f5a
Autor:
Yiting Geng, Xiao Zheng, Dachuan Zhang, Shanshan Wei, Jun Feng, Wei Wang, Luo Zhang, Changping Wu, Wenwei Hu
Publikováno v:
Biology Direct, Vol 19, Iss 1, Pp 1-15 (2024)
Abstract Epidermal growth factor receptor (EGFR)-targeted therapy is an important treatment for RAS wild-type metastatic colorectal cancer (mCRC), but the resistance mechanism remains unclear. Here, the differential expression of circRNAs between Cet
Externí odkaz:
https://doaj.org/article/ee4d73e8c2ab48c68bc10be1ac025155
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Effective identification and development of new molecular methods for the diagnosis, treatment and prognosis of lung adenocarcinoma (LUAD) remains an urgent clinical need. DNA methylation patterns at cytosine bases in the genome a
Externí odkaz:
https://doaj.org/article/d7b6653e64a84f48a98d16e2f9764a61
Autor:
Lujun Chen, Hao Huang, Ziyi Huang, Junjun Chen, Yingting Liu, Yue Wu, An Li, Junwei Ge, Zhang Fang, Bin Xu, Xiao Zheng, Changping Wu
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Tissue-resident CD8+T cells (CD103+CD8+T cells) are the essential effector cell population of anti-tumor immune response in tissue regional immunity. And we have reported that IL-33 can promote the proliferation and effector funct
Externí odkaz:
https://doaj.org/article/3715759e507344439ee822b3ceccaedd
Autor:
Xiao Zheng, Qi Wang, You Zhou, Dachuan Zhang, Yiting Geng, Wenwei Hu, Changping Wu, Yufang Shi, Jingting Jiang
Publikováno v:
Cancer Communications, Vol 42, Iss 12, Pp 1347-1366 (2022)
Abstract Background N‐acetyltransferase 10 (NAT10) is the only enzyme known to mediate the N4‐acetylcytidine (ac4C) modification of mRNA and is crucial for mRNA stability and translation efficiency. However, its role in cancer development and pro
Externí odkaz:
https://doaj.org/article/7ee8b4338b024a0f92ee33a98827a034
Publikováno v:
Medicine; 7/26/2024, Vol. 103 Issue 30, p1-7, 7p
Autor:
Shuizhong Cen, Mingxi Cai, Yihan Wang, Xiuyi Lu, Zhipeng Chen, Haobo Chen, Yingdong Fang, Changping Wu, Sujun Qiu, Zhenhua Liu
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Objective: We have already demonstrated that mesenchymal stem cells from patients with ankylosing spondylitis (ASMSCs) exhibited greater adipogenic differentiation potential than those from healthy donors (HDMSCs). Here, we further investigated the e
Externí odkaz:
https://doaj.org/article/0821fe39311b45cf9b623485df58a27f
Autor:
Min Yang, Bin Li, Yuan Li, Xiao Zheng, Junjun Chen, Hao Huang, Binfeng Lu, Runzi Sun, Lujun Chen, Bo Tan, Yingting Liu, Changping Wu, Jingting Jiang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Background Regulatory T cells (Treg) are an integral part of the tumor immune tolerance. Carcinoma-associated fibroblasts (CAFs) is a pivotal driver for accumulation of Treg cells in the tumor microenvironment (TME). The molecular nature underpinning
Externí odkaz:
https://doaj.org/article/7ec1853439384007806fa3b93600dff0
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-15 (2020)
Abstract Background Interleukin-33 (IL-33) is an effective inducer of pro-inflammatory cytokines regulating innate and adaptive immunity. Inflammation could be a double-edged sword, promoting or inhibiting tumour growth. To date, the roles and mechan
Externí odkaz:
https://doaj.org/article/afc64c7038844c3eaddb3245d6bd22c3
Autor:
Yaping Chen, Hao Huang, Yuan Li, Wenlu Xiao, Yingting Liu, Rongzhang Chen, Yulan Zhu, Xiao Zheng, Changping Wu, Lujun Chen
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundCombination immunotherapy based on immune checkpoint inhibitors (ICIs) has shown great success in the treatment of many types of cancers and has become the mainstream in the comprehensive treatment of cancers. Ablation in combination with i
Externí odkaz:
https://doaj.org/article/5d44186b7b264e919c34ea673119e3f8